CHICAGO (Reuters) - Using cervical fluid collected from routine Pap smears, U.S. researchers were able to spot genetic changes caused by both ovarian and endometrial cancers, offering promise for a new kind of screening test for these deadly cancers. Experts say that although the test has tremendous potential, it is still years from widespread use. But if proven effective with more testing, it would fill a significant void. Currently, there are no tests that can reliably detect either ovarian or endometrial cancer, which affects the uterine lining. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment